These included looking at how the liver damage had evolved after 52 weeks of treatment using a liver biopsy (when a small sample of liver tissue is taken and examined under a microscope), as well as measuring other signs of the disease such as the levels of ALT or of hepatitis B viral DNA circulating in the blood.